Annual Operating Profit
$978.90 M
-$12.00 B-92.46%
December 31, 2023
Summary
- As of February 7, 2025, BNTX annual operating income is $978.90 million, with the most recent change of -$12.00 billion (-92.46%) on December 31, 2023.
- During the last 3 years, BNTX annual operating profit has risen by +$1.07 billion (+1140.24%).
- BNTX annual operating profit is now -94.46% below its all-time high of $17.66 billion, reached on December 31, 2021.
Performance
BNTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$11.55 M
+$1.05 B+101.11%
September 1, 2024
Summary
- As of February 7, 2025, BNTX quarterly operating income is $11.55 million, with the most recent change of +$1.05 billion (+101.11%) on September 1, 2024.
- Over the past year, BNTX quarterly operating profit has dropped by -$785.36 million (-98.55%).
- BNTX quarterly operating profit is now -99.79% below its all-time high of $5.37 billion, reached on September 30, 2021.
Performance
BNTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$782.81 M
-$68.04 M-9.52%
September 1, 2024
Summary
- As of February 7, 2025, BNTX TTM operating income is -$782.81 million, with the most recent change of -$68.04 million (-9.52%) on September 1, 2024.
- Over the past year, BNTX TTM operating profit has dropped by -$1.75 billion (-181.11%).
- BNTX TTM operating profit is now -103.73% below its all-time high of $20.97 billion, reached on March 31, 2022.
Performance
BNTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BNTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.5% | -98.5% | -181.1% |
| 3 y3 years | +1140.2% | -99.8% | -103.7% |
| 5 y5 years | +1637.9% | +128.2% | -81.6% |
BNTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.5% | at low | -99.8% | +101.1% | -103.7% | at low |
| 5 y | 5-year | -94.5% | +581.8% | -99.8% | +101.1% | -103.7% | at low |
| alltime | all time | -94.5% | +581.8% | -99.8% | +101.1% | -103.7% | at low |
BioNTech SE Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $11.55 M(-101.1%) | -$782.81 M(+9.5%) |
| Jun 2024 | - | -$1.04 B(+88.8%) | -$714.77 M(+147.6%) |
| Mar 2024 | - | -$550.92 M(-169.1%) | -$288.66 M(-129.9%) |
| Dec 2023 | $978.90 M(-92.5%) | $796.91 M(+901.3%) | $965.11 M(-74.0%) |
| Sep 2023 | - | $79.59 M(-113.0%) | $3.71 B(-36.8%) |
| Jun 2023 | - | -$614.24 M(-187.4%) | $5.87 B(-31.2%) |
| Mar 2023 | - | $702.85 M(-80.1%) | $8.53 B(-35.2%) |
| Dec 2022 | $12.98 B(-26.5%) | $3.54 B(+58.2%) | $13.16 B(-11.5%) |
| Sep 2022 | - | $2.24 B(+9.3%) | $14.86 B(-17.4%) |
| Jun 2022 | - | $2.05 B(-61.6%) | $18.00 B(-14.2%) |
| Mar 2022 | - | $5.33 B(+1.7%) | $20.97 B(+19.2%) |
| Dec 2021 | $17.66 B | $5.24 B(-2.5%) | $17.59 B(+39.2%) |
| Sep 2021 | - | $5.37 B(+7.1%) | $12.64 B(+79.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $5.02 B(+156.8%) | $7.05 B(+263.5%) |
| Mar 2021 | - | $1.95 B(+571.1%) | $1.94 B(-2482.3%) |
| Dec 2020 | -$94.10 M(-53.7%) | $291.16 M(-233.6%) | -$81.35 M(-81.1%) |
| Sep 2020 | - | -$217.98 M(+144.7%) | -$431.12 M(+69.6%) |
| Jun 2020 | - | -$89.10 M(+36.2%) | -$254.14 M(+16.1%) |
| Mar 2020 | - | -$65.44 M(+11.7%) | -$218.82 M(+7.7%) |
| Dec 2019 | -$203.19 M(+219.2%) | -$58.61 M(+42.9%) | -$203.17 M(+37.9%) |
| Sep 2019 | - | -$41.00 M(-23.8%) | -$147.36 M(+12.1%) |
| Jun 2019 | - | -$53.77 M(+8.0%) | -$131.51 M(+69.2%) |
| Mar 2019 | - | -$49.79 M(+1683.5%) | -$77.74 M(+178.2%) |
| Dec 2018 | -$63.65 M(-8.3%) | -$2.79 M(-88.9%) | -$27.94 M(+11.1%) |
| Sep 2018 | - | -$25.15 M | -$25.15 M |
| Dec 2017 | -$69.40 M | - | - |
FAQ
- What is BioNTech SE annual operating income?
- What is the all time high annual operating profit for BioNTech SE?
- What is BioNTech SE annual operating profit year-on-year change?
- What is BioNTech SE quarterly operating income?
- What is the all time high quarterly operating profit for BioNTech SE?
- What is BioNTech SE quarterly operating profit year-on-year change?
- What is BioNTech SE TTM operating income?
- What is the all time high TTM operating profit for BioNTech SE?
- What is BioNTech SE TTM operating profit year-on-year change?
What is BioNTech SE annual operating income?
The current annual operating profit of BNTX is $978.90 M
What is the all time high annual operating profit for BioNTech SE?
BioNTech SE all-time high annual operating income is $17.66 B
What is BioNTech SE annual operating profit year-on-year change?
Over the past year, BNTX annual operating income has changed by -$12.00 B (-92.46%)
What is BioNTech SE quarterly operating income?
The current quarterly operating profit of BNTX is $11.55 M
What is the all time high quarterly operating profit for BioNTech SE?
BioNTech SE all-time high quarterly operating income is $5.37 B
What is BioNTech SE quarterly operating profit year-on-year change?
Over the past year, BNTX quarterly operating income has changed by -$785.36 M (-98.55%)
What is BioNTech SE TTM operating income?
The current TTM operating profit of BNTX is -$782.81 M
What is the all time high TTM operating profit for BioNTech SE?
BioNTech SE all-time high TTM operating income is $20.97 B
What is BioNTech SE TTM operating profit year-on-year change?
Over the past year, BNTX TTM operating income has changed by -$1.75 B (-181.11%)